Getting In Isn't the Hard Part

A health-tech founder I've been advising called me a few weeks ago with good news. They'd been accepted to a well-regarded accelerator with a digital health focus - real industry connections, a decent track record, recognizable names in the mentor network. They were excited, and understandably so.

Then we started talking through the actual decision.

The program takes a modest equity stake. Not unusual. And the founders were treating this as a straightforward cost-benefit question: is the equity worth the value we're getting? They were negotiating the number, comparing it to what they'd heard from other founders in other programs, trying to figure out if it was "fair."

The problem isn't that equity doesn't matter. It does. The problem is that both sides of that equation are more complicated than they appear - and founders who approach this as a simple trade tend to get it wrong in one direction or the other.

That conversation is one I've had a lot, from both sides of the table.

More programs, less clarity

There are thousands of accelerator programs running globally right now. They range from Y Combinator - $500k, roughly 7% equity, a real alumni network, and a brand that opens doors - to regional programs with a shared office, a list of mentors, and not much else. The marketing across all of them sounds more or less the same.

What does the data actually say? Research does find that accelerator participation tends to improve follow-on fundraising. That finding holds up fairly consistently across studies. But outcomes beyond fundraising - survival, revenue, exits - are much harder to attribute. Accelerators select companies that already have something going for them, so separating what the program caused from what those companies would have done anyway is genuinely difficult.

The variance in quality and relevance across programs is enormous, even among programs that look similar on paper. Sector focus, cohort stage, mentor quality, investor relationships, program intensity - all of it varies, and none of it is easy to assess from the outside. The pitch materials don't help you tell the difference. That's the actual challenge founders face when making this decision.

Before you say yes

I've used the same basic framework when advising founders on this, and when evaluating candidates for programs I've been involved with on the operator side.

What is your actual bottleneck right now?

Not what you wish you had - what is genuinely getting in your way this month. Usually it's one of: capital, specific introductions (investors or early customers), a credibility signal in your market, or structured accountability to keep you focused. Sometimes it's domain knowledge you don't have.

The challenge is being specific. "All of the above" isn't really an answer - it's a way of not answering. A program that directly addresses your actual constraint is worth serious consideration. One that doesn't won't move things forward much, regardless of how well-known it is.

Does this specific program actually deliver that thing?

Not according to their pitch - according to founders who went through it. Call them. Don't rely on testimonials or case studies; those are curated. Find alumni yourself and ask directly: did you get what you came for? Can you give me one concrete example of an introduction that actually went somewhere? What do you wish had been different?

The question founders tend to skip: "What's the one thing you expected and didn't get?" That one usually tells you more than everything else combined.

This is also where sector-specific programs sometimes do better than well-known generalist ones. A focused health-tech accelerator with genuine hospital system relationships and investors who actually understand the space may be more useful than a prestigious program where digital health is one of twenty verticals. Sector fit matters, and it's worth investigating specifically rather than assuming a good program is a good program for you.

Is this the best use of your time right now?

This is the question I almost never hear founders ask, and in my view it's often the most consequential one - more so, sometimes, than the equity.

Here's why. Equity is a cost that shows up on a cap table and stays visible. Time is a cost that doesn't show up anywhere, which makes it easy to underestimate. For a two-person pre-seed team, three to four months is a significant portion of your runway in time, even if the program isn't burning cash. One structured afternoon per week sounds manageable until you account for prep, informal sessions, the cohort group chat, the mental space it occupies. And the question isn't just how much time - it's what you're not doing with it.

The right way to frame this: where will you be in three months if you join, compared to where you'd be if you don't? How far along on product? How many customer conversations deep? How close to the next real milestone?

If the gap is significant - if the program's network or structure genuinely accelerates those things - that's the actual return on the equity. But if the honest answer is "roughly the same place," then you're paying equity for something that isn't moving your company forward. That's worth knowing before you sign.

Is this the right moment in your company's life for a program at all?

Q3 is about opportunity cost during the program - what you give up while you're enrolled. This question is a step further back: it asks whether your company is even at the right stage for an accelerator right now, regardless of which one.

Join too early - no product, no real hypothesis, no customer conversations to speak of - and you spend the program working through things you'd have worked through anyway, just slower and in a group setting. Join with meaningful traction, paying customers, and a clear direction, and you may find the program adds overhead without proportionate return. There's a window where accelerators tend to work well. It's worth locating honestly before you decide, because the program's interest in having you join and your interest in joining aren't always the same thing.

What I see from the other side

The four questions above come from the advisor side of the table. Running a program gives you a different view.

I'm a partner in a MusicTech accelerator based in Tel Aviv, which means I've sat on both sides of this conversation - evaluating founders as candidates, and then watching what actually delivers value once they're in. A few things look different from inside.

The curriculum is rarely where the real value lives. Even a well-designed one covers material that motivated founders could find on their own. The books exist, the frameworks are documented, experienced advisors are accessible. What's harder to replicate is the combination of things that only come from being inside a good program at the right moment: mentors who have navigated the specific regulatory, commercial, or technical terrain you're in and can give you an hour of hard-won insight; investors who understand your sector and are actively looking at companies at your stage; connections to potential customers or partners who take your call because of who introduced you. These things exist outside accelerators too, but a good program concentrates them and creates the conditions for them to actually happen.

And then there's the cohort. Cohort composition matters more than almost anything else in determining whether a program delivers. The programs that work best are deliberate about stage uniformity - companies at similar moments, facing similar questions. That's what makes peer learning real. A mixed cohort, where one company is pre-revenue and another already has paying customers, doesn't serve either of them particularly well. When you're evaluating a program, ask about who else is likely to be in the cohort as seriously as you ask about the mentors.

The peer relationships that form often last longer than anything else the program produces. Cohort alumni become each other's angel investors, advisors, and sounding boards years later. It's one of the harder things to evaluate from the outside because it doesn't show up in the marketing - and it's one of the things that's genuinely hard to replicate without the structure.

The mistake I keep seeing - from both directions

Running an accelerator and advising founders who are considering them gives you a particular vantage point: you see the same mistake from two directions.

From the operator side, I've seen founders join a program and realize within a few weeks it wasn't right for them - wrong stage, wrong fit, wrong moment. The decision was made on incomplete evaluation of what the program actually offered and what they actually needed. I've also seen founders who were strong candidates talk themselves out of applying because the equity felt expensive - without ever seriously working through what that equity might return over a five-year horizon.

From the advisor side, same thing in reverse. Founders who joined because the program had a recognizable name, without asking whether it addressed their real constraint. And founders who walked away from genuinely useful programs because the equity number felt high, without doing the calculation.

Both mistakes come from the same root: treating the decision as simpler than it is. The costs aren't just equity, and the benefits aren't just what's in the pitch deck.

Back to the health-tech founders. We spent about an hour on these questions. The bottleneck question was the most useful - what they actually needed was warm introductions to investors who understand regulated health markets specifically. The question was whether this program could deliver that, or whether "investor network" meant something more general.

They went back to the program with more specific questions. The answers were clearer than they expected.

They're joining.

Maybe that's the right call. I won't know for a while. But they're going in with a clearer picture of what they're there for, which is a better starting point than most founders have.

I help founders navigate strategy and funding decisions when the path isn't clear. If you're there, let's talk.